INV SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Innventure (INV) Investors of Securities Class Action Lawsuit Deadline on October 27, 2026

Faruqi & Faruqi is investigating potential securities-law claims against Innventure (NASDAQ: INV) and notes that a federal securities class action has been filed. Investors who bought Innventure securities between November 17, 2025 and August 13, 2026 have until October 27, 2026 to seek appointment as lead plaintiff. The litigation notice signals potential investor-loss and disclosure-related risks for Innventure, though it provides no damages estimate or underlying allegations.

Analysis

This is a litigation-advertisement signal rather than new fundamental disclosure, so the standalone information edge is weak. The near-term market effect is nevertheless asymmetric for INV if the stock has limited liquidity or elevated short interest: plaintiff-deadline publicity can widen spreads, reduce marginal long-only sponsorship, and create forced selling from holders with litigation-risk screens. Do not infer damages or operating impairment from the filing absent an underlying corrective disclosure, restatement, SEC action, or guidance revision.

Over the next 1-3 months, the relevant catalyst path is discovery of whether the alleged conduct maps to a measurable earnings, cash-burn, customer-concentration, or disclosure-control issue. A lead-plaintiff deadline on its own rarely determines enterprise value; the material risk is that it prompts management to reserve cash, distracts capital-raising efforts, or exposes financing covenants if INV needs external capital. For a company with venture-building economics, any increase in its cost of capital can be more consequential than a prospective settlement because it reduces the valuation assigned to long-dated, unproven assets.

Contrarianly, litigation headlines often create temporary price pressure that shorts mistake for a fundamental catalyst. If no independent disclosure emerges by the deadline and borrow remains expensive, covering risk rises after the event. The thesis turns decisively bearish only if management revises revenue/EBITDA guidance, reports weaker liquidity runway, identifies control deficiencies, or the SEC opens a formal proceeding; otherwise this is an alert, not a high-conviction directional signal.

Key Decisions for Investors

• Do not initiate a core short in INV solely on this notice. Monitor daily volume, securities-lending utilization/borrow cost, and the underlying complaint; consider a tactical short only after a close below the pre-notice support level accompanied by at least 2x normal volume and a new fundamental disclosure.
• For existing INV longs, reduce position size ahead of the October 27 lead-plaintiff deadline if liquidity is thin; retain exposure only against a predefined stop tied to a guidance cut, liquidity-runway deterioration, or SEC inquiry rather than the legal headline itself.
• Set a 1-3 month catalyst watch for the next earnings release: cash balance, quarterly operating cash burn, financing needs, revenue recognition disclosures, and any change in auditor or internal-control language. A negative surprise on any of these items would validate a short thesis more reliably than litigation publicity.
• If INV sells off sharply into the deadline without corroborating news, evaluate a small, tightly risk-controlled mean-reversion long only after borrow data show short-covering vulnerability and price stabilizes for several sessions; invalidate on any restatement, formal regulatory action, or revised outlook.